[Principles of multidisciplinary management of Duchenne muscular dystrophy]

B Chabrol1, M Mayer2

  • 1Centre de référence des maladies neuromusculaires de l'enfant, Hôpital d'Enfants, CHU Timone, 13385 Marseille cedex 5.

Insights

Multidisciplinary care is crucial for Duchenne muscular dystrophy (DMD) patients, ensuring continuous support from diagnosis through adulthood. Effective communication and a structured care plan are vital for managing this progressive condition.

Area of Science:

  • Neurology
  • Pediatrics
  • Genetics

Background:

  • Duchenne muscular dystrophy (DMD) is a progressive genetic disorder.
  • Advances in management have increased lifespan, with over 90% of children now reaching adulthood.
  • Care transitions from pediatric to adult services present significant organizational challenges.

Purpose of the Study:

  • To emphasize the importance of multidisciplinary consultations for optimal Duchenne muscular dystrophy (DMD) management.
  • To highlight the necessity of clear communication and phased information delivery to children and parents regarding diagnosis and symptoms.
  • To address the challenges and importance of care continuity during the transition from pediatric to adult care.

Main Methods:

  • Review of current care strategies for Duchenne muscular dystrophy (DMD).
  • Analysis of communication protocols for diagnosis announcement and ongoing patient support.
  • Examination of care transition models from pediatric to adult services.

Main Results:

  • Multidisciplinary care organization is essential for managing the diverse aspects of Duchenne muscular dystrophy (DMD).
  • Early, clear, and age-appropriate communication is fundamental for patient and family understanding.
  • Care continuity and support throughout the disease trajectory, including terminal phases, are critical.

Conclusions:

  • Optimizing Duchenne muscular dystrophy (DMD) care requires a coordinated, multidisciplinary approach.
  • Effective communication strategies and seamless care transitions are paramount for improving patient outcomes and quality of life.
  • Ongoing therapeutic trials must complement, not replace, comprehensive patient management and support.

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
616
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.6K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
621
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.3K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
744
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.3K